Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice

Journal of Clinical Investigation

Volumn 119, Issue 6, 2009, Pages 1659-1667

  Uebele, Victor N ^a   Gotter, Anthony L ^a   Nuss, Cindy E ^a   Kraus, Richard L ^a   Doran, Scott M ^a   Garson, Susan L ^a   Reiss, Duane R ^a   Li, Yuxing ^a   Barrow, James C ^a   Reger, Thomas S ^a   Yang, Zhi Qiang ^a   Ballard, Jeanine E ^a   Tang, Cuyue ^a   Metzger, Joseph M ^a   Wang, Sheng Ping ^a   Koblan, Kenneth S ^a   Renger, John J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; TTA A 2; TTA A 7; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; BODY TEMPERATURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; HUMAN CELL; LIPID DIET; MALE; MAXIMUM PLASMA CONCENTRATION; METABOLIC RATE; MOUSE; MUSCLE MASS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SLEEP; TIME TO MAXIMUM PLASMA CONCENTRATION; WEIGHT CONTROL; WEIGHT GAIN;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; DIETARY FATS; MALE; MICE; MICE, KNOCKOUT; MOLECULAR STRUCTURE; RATS; WEIGHT GAIN;

EID: 67650996959     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI36954     Document Type: Article

References (52)

1. Aparecida Crispim, C., et al. 2007. The influence of sleep and sleep loss upon food intake and metabolism. Nutr. Res. Rev. 20:195-212.
2. D'Arrigo, T. 2007. The secret life of Zs. A good night's sleep can help you lose weight. Diabetes Forecast. 60:24.
3. Laposky, A.D., Bass, J., Kohsaka, A., and Turek, F.W. 2008. Sleep and circadian rhythms: Key components in the regulation of energy metabolism. FEBS Lett. 582:142-151.
4. Pearson, H. 2006. Medicine: sleep it off. Nature. 443:261-263.
5. Penev, P.D. 2007. Sleep deprivation and energy metabolism: to sleep, perchance to eat? Curr. Opin. Endocrinol. Diabetes Obes. 14:374-381.
6. Ramsey, K.M., Marcheva, B., Kohsaka, A., and Bass, J. 2007. The clockwork of metabolism. Annu. Rev. Nutr. 27:219-240.
7. Taheri, S. 2007. Sleep and metabolism: bringing pieces of the jigsaw together. Sleep Med. Rev. 11:159-162.
8. Van Cauter, E., Polonsky, K.S., and Scheen, A.J. 1997. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr. Rev. 18:716-738.
9. Van Itallie, T.B. 2006. Sleep and energy balance: Interactive homeostatic systems. Metabolism. 55:S30-S35.
10. Kohsaka, A., et al. 2007. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab. 6:414-421.
11. Shaaban, S.Y., Ei-Sayed, H.L., Nassar, M.F., Asaad, T., and Gomaa, S.M. 2007. Sleep-wake cycle disturbances in protein-energy malnutrition: effect of nutritional rehabilitation. East Mediterr. Health J. 13:633-645.
12. Guesdon, B., Minet-Ringet, J., Tome, D.G., and Even, P.C. 2005. Restriction-refeeding of calories and protein induces changes to slow wave and paradoxical sleep that parallel changes in body lipid and protein levels in rats. Behav. Brain Res. 164:156-164.
13. Jenkins, J.B., et al. 2006. Sleep is increased in mice with obesity induced by high-fat food. Physiol. Behav. 87:255-262.
14. Banks, S., and Dinges, D.F. 2007. Behavioral and physiological consequences of sleep restriction. J. Clin. Sleep Med. 3:519-528.
15. Bjorvatn, B., et al. 2007. The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study. J. Sleep Res. 16:66-76.
16. Knutson, K.L., Spiegel, K., Penev, P., and Van Cauter, E. 2007. The metabolic consequences of sleep deprivation. Sleep Med. Rev. 11:163-178.
17. Scheen, A.J., Byrne, M.M., Plat, L., Leproult, R., and Van Cauter, E. 1996. Relationships between sleep quality and glucose regulation in normal humans. Am. J. Physiol. 271:E261-E270.
18. Schmid, S.M., et al. 2007. Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia. J. Clin. Endocrinol. Metab. 92:3044-3051.
19. Spiegel, K., Leproult, R., and Van Cauter, E. 1999. Impact of sleep debt on metabolic and endocrine function. Lancet. 354:1435-1439.
20. Spiegel, K., Tasali, E., Penev, P., and Van Cauter, E. 2004. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann. Intern. Med. 141:846-850.
21. Spiegel, K., Knutson, K., Leproult, R., Tasali, E., and Van Cauter, E. 2005. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J. Appl. Physiol. 99:2008-2019.
22. Tasali, E., Leproult, R., Ehrmann, D.A., and Van Cauter, E. 2008. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc. Natl. Acad. Sci. U. S. A. 105:1044-1049.
23. Van Cauter, E., et al. 2007. Impact of sleep and sleep loss on neuroendocrine and metabolic function. Horm. Res. 67(Suppl. 1):2-9.
24. Verhulst, S.L., et al. 2008. Sleep duration and metabolic dysregulation in overweight children and adolescents. Arch. Dis. Child. 93:89-90.
25. Spiegel, K., et al. 2004. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J. Clin. Endocrinol. Metab. 89:5762-5771.
26. Talley, E.M., et al. 1999. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J. Neurosci. 19:1895-1911.
27. Contreras, D. 2006. The role of T-channels in the generation of thalamocortical rhythms. CNS Neurol. Disord. Drug Targets. 5:571-585.
28. Llinas, R.R., and Steriade, M. 2006. Bursting of thalamic neurons and states of vigilance. J. Neurophysiol. 95:3297-3308.
29. Steriade, M. 2003. The corticothalamic system in sleep. Front. Biosci. 8:d878-d899.
30. Steriade, M., McCormick, D.A., and Sejnowski, T.J. 1993. Thalamocortical oscillations in the sleeping and aroused brain. Science. 262:679-685.
31. Kim, D., et al. 2001. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron. 31:35-45.
32. Lee, J., Kim, D., and Shin, H.S. 2004. Lack of delta waves and sleep disturbances during non-rapid eye movement sleep in mice lacking alpha1G-subunit of T-type calcium channels. Proc. Natl. Acad. Sci. U. S. A. 101:18195-18199.
33. Lee, J., and Shin, H.S. 2007. T-type calcium channels and thalamocortical rhythms in sleep: a perspective from studies of T-type calcium channel knockout mice. CNS Neurol. Disord. Drug Targets. 6:63-69.
34. Anderson, M.P., et al. 2005. Thalamic CaV3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep. Proc. Natl. Acad. Sci. U. S. A. 102:1743-1748.
35. Nagashima, K., et al. 2003. Effects of fasting on thermoregulatory processes and the daily oscillations in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:R1486-R1493.
36. Shearman, L.P., et al. 2003. Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. Eur. J. Pharmacol. 475:37-47.
37. Shipe, W.D., et al. 2008. Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca(2+) channel antagonist. J. Med. Chem. 51:3692-3695.
38. Pack, A.I., et al. 2007. Novel method for high-throughput phenotyping of sleep in mice. Physiol. Genomics. 28:232-238.
39. Zhu, J., Zhang, B., and Schadt, E.E. 2008. A systems biology approach to drug discovery. Adv. Genet. 60:603-635.
40. Chen, Y., et al. 2008. Variations in DNA elucidate molecular networks that cause disease. Nature. 452:429-435.
41. Lum, P.Y., et al. 2006. Elucidating the murine brain transcriptional network in a segregating mouse population to identify core functional modules for obesity and diabetes. J. Neurochem. 97(Suppl. 1):50-62.
42. Masaki, T., et al. 2004. Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes. 53:2250-2260.
43. Turek, F.W., et al. 2005. Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 308:1043-1045.
44. Green, C.B., Takahashi, J.S., and Bass, J. 2008. The meter of metabolism. Cell. 134:728-742.
45. Allison, K.C., et al. 2007. Binge eating disorder and night eating syndrome in adults with type 2 diabetes. Obesity (Silver Spring). 15:1287-1293.
46. Blackburn, G.L., and Waltman, B.A. 2005. Pharmacotherapy to reduce visceral fat. Clin. Cornerstone. 7:52-60.
47. Hamdy, O., Porramatikul, S., and Al Ozairi, E. 2006. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr. Diabetes Rev. 2:367-373.
48. Iannucci, C.V., Capoccia, D., Calabria, M., and Leonetti, F. 2007. Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets. Curr. Pharm. Des. 13:2148-2168.
49. Rodriguez, A., Catalan, V., Gomez-Ambrosi, J., and Fruhbeck, G. 2007. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Curr. Pharm. Des. 13:2169-2175.
50. Thalmann, S., and Meier, C.A. 2007. Local adipose tissue depots as cardiovascular risk factors. Cardiovasc. Res. 75:690-701.
51. Dai, G., et al. 2008. A high-throughput assay for evaluating state dependence and subtype selectivity of CaV2 calcium channel inhibitors. Assay Drug Dev. Technol. 6:195-212.
52. Renger, J.J., Dunn, S.L., Motzel, S.L., Johnson, C., and Koblan, K.S. 2004. Sub-chronic administration of zolpidem affects modifications to rat sleep architecture. Brain Res. 1010:45-54.